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Abstract
Hepatitis C virus (HCV) is a major health problem in developing countries including Pakistan. Chronic HCV infection
results in progressive liver disease including fibrosis, cirrhosis, insulin resistance and eventually hepatocellular
carcinoma (HCC). Ionotrophic purinergic (P2X) receptors are identified to involve in a spectrum of physiological
and pathophysiological processes. However, the role of P2X receptors in HCV liver associated diseases still remains
to be investigated. The current study was designed to identify the presence of P2X receptors in human liver cells.
Furthermore, it investigates the response of P2X receptors towards HCV structural proteins (E1E2). To determine
that how many isoforms of P2X receptors are expressed in human liver cells, human hepatoma cell line (Huh-7)
was used. Transcripts (mRNA) of five different isoforms of P2X receptors were identified in Huh-7 cells. To examine
the gene expression of identified isoforms of P2X receptors in presence of HCV structural proteins E1E2, Huh-7/
E1E2 cell line (stably expressing HCV structural proteins E1E2) was used. The results showed significant increase (6.2
fold) in gene expression of P2X4 receptors in Huh-7/E1E2 cells as compared to control Huh-7 cells. The findings of
present study confirmed the presence of transcripts of five different isoforms of P2X receptors in human liver cells
and suggest that P2X4 receptors could be represented an important component of the purinergic signaling
complex in HCV induced liver pathogenesis.
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Background
Hepatitis C virus (HCV) is blood borne pathogen which
is a major cause of different liver associated diseases
varying from an asymptomatic condition to hepatocellu-
lar carcinoma (HCC) [1-5]. It is estimated that 3.3% of
the population globally and 10% of the Pakistani popula-
tion is chronically infected with HCV [6,7]). The gen-
ome of HCV is 9.6-kb-long, which predetermines a
polyprotein of about 3,010 amino acids and encodes 3
structural (core, E1, E2, p7) and 7 nonstructural (P7,
NS2, NS3, NS4A, NS4B, NS5A, NS5B) proteins [3,8-10].
These viral proteins not only function in viral replica-
tion but also dysregulate a variety of cellular functions
[1,11,12].
During their synthesis, HCV envelope proteins E1E2
are inserted into the membranes of endoplasmic reticu-
lum (ER). Immunolocalization studies have revealed the
presence of E1E2 in the ER [13]. Liver mitochondria
from transgenic mice expressing the HCV proteins core,
E1 and E2, showed a significant decrease in mitochon-
drial glutathione and reduced activity and increased
reactive oxidative species (ROS) production from mito-
chondrial electron transport complex I. These results
s u g g e s tt h a tc h a n g e si nm i t o chondrial glutathione and
complex I inhibition induced by core, E1 and E2 is an
important cause of the oxidative stress seen in chronic
hepatitis C [14]. Therefore, HCV envelope glycoproteins
(E1E2) are a good candidate to study the HCV induced
ROS, very well known reported to play a key role in the
development of hepatic and extrahepatic complications
in HCV chronic infection [15]. The major HCV geno-
type in Pakistan is 3a, with a strong association between
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correlated with genotype 3a [6,16,17].
Significant attention is presently being drawn towards
the HCV modulated molecular pathways that lead to
liver pathogenesis [18,19]. Although many of the signals
that regulate induction of liver pathogenesis have been
defined, however, the second messengers by whom
these signals are transduced are not as well established
[20]. Adenosine 5’-triphosphate (ATP) functions as
potent autocrine/paracrine signaling molecule in hepato-
cytes [21]. ATP can be released to the extracellular
milieu under pathophysiological conditions such as
stress, hypoxia, mechanical and osmotic strain and
increase in cell volume [21,22]. ATP mediates its various
effects by binding to and activation of Purinergic recep-
tors [23]. Purinergic receptors are classified into two
main types, P1 and P2 [24]. P2 receptors are further
classified into two major types: P2X (ionotropic), and
P2Y (metabotropic). Different isoforms of P2X recep-
tors, expressed on various cells are identified to involve
in a spectrum of physiological and pathophysiological
processes, including synaptic transmission, pain and
touch perception, vasomotor responses, platelet aggrega-
tion, endothelial release of vasorelaxants, cell volume
regulation, cell proliferation and mitogenesis, apoptosis,
wound healing, restenosis, atherosclerosis, ischaemia,
inflammation, collagen deposition, and fibrosis [25-27].
The present study was undertaken to identify the pre-
sence of various isoforms of P2X receptors in human
hepatoma cell (Huh-7) and to evaluate the response of
identified isoforms to HCV structural proteins E1E2.
The findings of the current study demonstrated that
each of these isoforms of P2X receptors respond differ-
ently to HCV structural proteins E1E2. This is one of
the first studies which may open a new insight into the
pathogenic mechanisms leading to HCV induced liver
pathogenesis via Purinergic (P2X) receptor signaling.
Methods
Cell lines and Culture Conditions
The cell lines used in this study, Huh-7 and Huh-7/
E1E2 were kindly provided by Dr. Zafar Nawaz (Univer-
sity of Miami, USA) and Dr. Muhammad Idrees
(Incharge Molecular Virology Division, CEMB, univer-
sity of the Punjab, Lahore, Pakistan respectively. The
Huh-7/E1E2 cell line was derived from the parental
Huh-7 cell line. The Huh-7/E1E2 cell line was a stable
clone of Huh-7 cells transfected with and stably over-
expressing HCV Proteins E1E2 (derived from local HCV
isolates of genotype 3a) linked to the antibiotic selection
marker G418 which was under the control of human
cytomegalovirus promoter [28] Huh-7 cell line was cul-
tured in Dulbecco Modified Eagle’s Medium (DMEM)
supplemented with 100 U/ml of penicillin and 100 ug/
ml of streptomycin and 10% heat inactivated fetal
bovine serum (complete DMEM medium). Huh-7/E1E2
cell line was maintained in complete medium containing
500 μg/ml G418. The medium was replaced every third
day, and cells were passaged every 4-5 days. All cells
were maintained at 37°C in a humidified environment
containing 5% CO2 in a cell culture incubator.
RNA Isolation, quantification, and cDNA Synthesis
Total RNA from Huh-7 and Huh-7/E1E2 cells was
isolated using Gentra RNA Isolation Kit (Puregene,
Minneapolis, MN 55441, USA), following the manufac-
turer’s instructions. Each sample of isolated RNA was
further treated with DNase (Fermentas) to remove any
residual DNA present that could generate false -positive
results. Quantity and quality of extracted RNA was
assessed using NanoDrop
® (Spectrophotometer) (ND-
1000). Quality of extracted RNA was also checked on
agarose gel electrophoresis using 1% agarose gel, stained
with ethidium bromide and photographed. To investi-
gate the presence of isoforms of P2X receptors cDNA
was synthesized with 1 μga n d5μg of total isolated
RNA using RevertAid™ Hm i n u sF i r s tS t r a n dc D N A
synthesis kit (Fermentas, Cat no.K1632). All the tubes,
pipette tips and containers used in the RNA isolation
and cDNA synthesis were either manufacturer certified
RNAase free or were made RNAase free by treating
with 1% DEPC treated water and were autoclaved
before use.
Detection of P2X receptor transcripts Using RT-PCR
Independent sense and antisense primers were designed
for P2X6 from known cloned receptor sequences, avail-
able in GenBank using primer 3 software, and were
synthesized by the core synthesis facility of the centre
(CEMB). Previously published primer sequences were
used for the remaining receptors, P2X1, P2X2, P2X3,
P2X4, P2X5, and P2X6. Primer sequences are shown in
Table 1. PCR conditions for amplification of P2X2,
P2X3 and P2X5 were 90°C (10 min), 35 cycles [95°C (45
s), 60°C (45 s) and 72°C (45 s)], and 72°C (10 min), PCR
conditions for P2X4 were 94°C for 45 s 35 cycles [94°C
(1 min), 60°C (45 s) and 72°C (1 min)], and 72°C 10
min. PCR amplifications were repeated using 10 separate
preparations of synthesized cDNA, from 10 separate
experiments to confirm the consistency of results
obtained. Two different concentrations of cDNA (1 μg
&5μg) were used for optimization of PCR amplifica-
tion, so that if any isoform has a faint expression in
Huh-7 cell, then could also be detected at 5 μg/μl
cDNA concentration. Amplification products were sepa-
rated by gel electrophoresis (2% agarose) and visualized
with ethidium bromide staining. PCR products were
extracted by using a QIAEX II Gel Extraction Kit
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cer to confirm their identities.
Quantification of P2X receptors transcripts
Real time qRT-PCR was performed to examine the
mRNA expression of identified isoforms of P2X recep-
tors in Huh-7/E1E2 cell line compared to wild type/par-
ental Huh-7 cells as control. Equal numbers of cells (3
× 10
5/culturing flask) of both cell lines were plated in
25 cm
2 culturing flasks (6culturing flasks, 1 for each cell
line in 3 separate studies) at the same time and kept at
37°C incubator in humid air with 5% CO2. On 4 day,
media was removed; cells were washed with sterile 1X
PBS (Phosphate Buffer Saline), trypsinized using 0.5%
trypsin in EDTA. The RNA extractions and cDNA
s y m t h e s i sw e r ed o n eG e n t r a RNA Isolation Kit (Pure-
gene, Minneapolis, MN 55441, USA) and RevertAid™
H minus First Strand cDNA synthesis kit (Fermentas,
Cat no.K1632) respectively as per manufacturer’s
instructions.
Quantification of P2X receptors RNAs was performed
by Real Time PCR Cepheid smart cycler II (France).
The relative levels of P2X2, P2X3, P2X4, P2X5, P2X6
genes were determined using GAPDH mRNA for nor-
malization. The calculation was based on the Δ-Ct
(Threshold cycle number difference between control,
Huh-7, and Huh-7/E1E2 cells), and the ratios were nor-
malized to the ratios of GAPDH of the corresponding
samples. Some isoforms were unresponsive to HCV
structural proteins E1E2, while some were responsive.
The most responsive isoform was P2X4.
Statistical Analysis
All statistical analysis was performed with GraphPad
Prism 5 software Version 5.02. Data are presented as
mean ± SEM. Comparisons between parameters were
p e r f o r m e du s i n gA N O V Af o l l o w e db yB o n f e r r o n io r
unpaired t test. A p-value of less than or equal to 0.05
was considered statistically significant.
Results
Identification of P2X receptors mRNA in Huh-7 cell line
To evaluate whether transcripts for P2X receptors are
present in human liver cells, total cellular RNA was
extracted from human hepatoma cell line (Huh-7) and
was analyzed by RT PCR using primers specific for
P2X1 through P2X7 (Table 1). Amplification of GAPDH
mRNA served as an internal control. In whole liver,
which is composed primarily of hepatocytes but also
includes multiple additional cell types, mRNA for differ-
ent isoforms of P2X receptors, P2X2, P2X3, P2X4, P2X5
and P2X6 were detected by RT- PCR in 10 separate stu-
dies. All studies were performed under identical culture
conditions using cells from passage 5-15 and capable of
forming differentiated monolayers. Figure 1 shows the
detection of transcripts of different isoforms of P2X
receptors in Huh-7 cell line.
Identification of amplified transcripts was confirmed
by sequencing PCR. The purified DNA of P2X2, P2X3,
P2X4, P2X5 and P2X6 were used as templates for
sequencing PCR in the Big-Dye Terminator Cycle
Sequencing Ready Reaction Kit (Applied Biosystems).
Samples were analyzed on an automated sequencer (ABI
PRISM 3100 genetic analyzer; Applied Biosystems). Pro-
ducts were sequenced from both strands to confirm
their identity with reference sequences.
Sequences of the sequenced transcripts of P2X recep-
tors were searched for homology with other sequences
in GeneBank using Blast2 (Basic Local Alignment
Search Tool), at http://www.ncbi.nlm.nih.gov/BLAST/
Sequences of amplified P2X receptors showed 96-100%
Table 1 Sequences of primers used for PCR amplification
of P2X receptors inHuh-7 Cells
No. Primer Name Primer Sequence: 5’-3’ Sequence
1 P2X2- F CAGGTTTGCCAAATACTACAAGATCA
2 P2X2 -R AACTTCCCGGCCTGTCCAT
3 P2X3- F TCTTCACCTATGAGACCACCAAGTC
4 P2X3-R GATCAGAAGCTGAACTACTCGGTTGATG
5 P2X4 -F CTC TGCTTGCCCAGGTACTC
6 P2X4- R CCAGCTCACTAG CAAGACCC
7 P2X5- F CGCTGGGGAAGCGGTTA
8 P2X5- R GCACCAGGCAAAGATCTCACA
9 P2X6 -F GAACCACAATTCAGCCCCTA
10 P2X6 -R CAGGTCACAATCCCAGTGAA
11 GAPDH-F ACCACAGTCCATGCCATCAC
12 GAPDH-R TCCACCACCCTGTTGCTGTA
Figure 1 Identification of P2X receptor transcripts in Huh-7 cell
line. Human liver cells (Huh-7 cell) express multiple P2X receptor
isoform transcripts. Representative products of the appropriate size
were detected for receptors P2X2, P2X3, P2X5, P2X6 and P2X4. P2X1
and P2X7 were not detected over a broad range of conditions. PCR
amplifications for all detected isoforms were repeated using 10
separate preparations of synthesized cDNA, from 10 separate
experiments. All these identified isoforms were always present (10/
10).
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numbers, HQ323686, JF807485).
Expression of P2X receptors in the presence of HCV
structural proteins E1E2
To examine the mRNA expression of identified isoforms
of P2X receptors in presence of HCV structural proteins
E1E2, Real time qRT-PCR was performed. A significant
increase (6.2 fold) was observed in the gene expression
of P2X4 receptor in Huh-7/E1E2 cells (stably expressing
HCV structural protein E1E2) in comparision with con-
trol Huh-7 cells (Figure 2). Whereas expression of P2X5
receptor decreased significantly in Huh-7/E1E2 cells
(Figure 2). However, P2X2, P2X3 andP2X6 were unre-
sponsive to E1E2.
Discussion
Evidences showed the role of ATP as persuasive auto-
crine/paracrine signaling molecule in hepatocytes [21].
ATP mediates its different effects by binding to and
activation of Purinergic receptors [23]. Purinergic recep-
tors are reported to be involved in a spectrum of phy-
siological and pathophysiological processes [24-29]. P2X
receptors have previously been shown to be associated
in mediating apaoptotic, inflammatory, fibrogenic and
matrix deposition responses caused by various etiologi-
cal factors [30].
Different isoforms of P2X receptors are expressed
widely in the body [31]. Previous reports have demon-
strated the presence of different transcripts of P2X
receptors, P2X1, P2X2, P2X3, P2X4 and P2X7 in rat
liver cells and rat hepatocytes [32]. In current study we
have showed the detection of different transcripts of
P2X receptors in Huh-7 and Huh-7/E1E2 cells.
The most important and interesting finding of the
present study is the observation that each of these iso-
forms of P2X receptors responded differently to HCV
structural proteins E1E2. A significant increase (6.2 fold)
was observed in the expression of P2X4 receptor in
Huh-7/E1E2 cells (stably expressing HCV structural
protein E1E2) in comparison with control Huh-7 cells.
On the other hand expression of P2X5 receptor
decreased significantly in Huh-7/E1E2 cells. It has been
noted in the current study that P2X2, P2X3 and P2X6
were unresponsive to E1E2. P2X4 receptors were origin-
ally identified in brain tissues where they showed unique
pharmacological profile [33,34]. Previous studies provide
evidence that this isoform is functionally important in
hepatic functions such as regulation of hepatic glycogen
metabolism in rat liver cells (Emmett, et al., 2007), in
modulating biliary secretion in rat cholangiocytes [34].
There are no previous reports in literature regarding the
effects of HCV proteins on the expression of P2X recep-
tors. To the best of our knowledge the present study
investigated the effects of HCV structural proteins on
expression of P2X receptors for the first time.
Conclusion
Taken together, these findings provide molecular evi-
dence that P2X receptors are also present in human
liver cells (Huh-7 cell line), and indicated that P2X
receptors respond towards HCV structural proteins
E1E2 of genotype 3a, P2X4 is one of the most respon-
sive isoforms. Furthermore, these findings also suggest
that the most responsive isoform P2X4 receptors could
be represented a novel and functionally important com-
ponent of the purinergic signaling complex in HCV
induced pathogenesis. Therefore, the further additional
studies also suggested for understanding the interaction
of P2X receptors and HCV genome, role of P2X recep-
tors signaling in HCV induced liver pathogenesis.
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Figure 2 P2X receptors genes expression analysis in Huh-7/
E1E2 compared to Huh-7 cell line. All values were expressed as
mean ± SEM *P ≤ 0.05 vs. control Huh-7. Results were obtained
from 6 independent experiments with replicate samples in each
experiment are shown. P2X4 showed most response to HCV
structural proteins E1E2.
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